Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 152 for “"antisense oligonucleotide"”.
-
Predicting Antisense Oligonucleotide Thermodynamics using Deep Learning
Antisense oligonucleotides (ASOs) have emerged as a promising approach in medicine for the treatment of diseases associated with disrupted protein production. However, the lengthy drug discovery process poses a significant challenge. This project aimed to address this challenge by developing a …
-
Delivery and stability of antisense oligonucleotide conjugates in vitro
The efficacy of antisense oligonucleotide (ODN) therapy is dependent on four major parameters: delivery to cells, intracellular stability and localisation and efficient action at the target site.The aim of this project was to study the delivery of ODNs to macrophages and to assess the stability of …
-
Antisense Oligonucleotide-Loaded Liposomes for Gene Silencing in Bacterial Biofilms
… of cationic liposomes encapsulated with antisense oligonucleotides. The liposomes themselves were synthesized via a microfluidic system to ensure uniform particle size distribution conducive to bacterial biofilm uptake. Furthermore, the various liposome samples exhibited favourable …
-
ENHANCE ROBUSTNESS OF DETRITYLATION STEP IN SOLID PHASE ANTISENSE OLIGONUCLEOTIDE SYNTHESIS
Antisense Oligonucleotide (ASO) based drugs are now novel and promising therapeutics for treating a large variety of diseases. ASOs are single strand short nucleotides that are typically 15-25 nucleotides long. They target mRNAs instead of normal protein receptors and bring therapeutic …
-
Down-regulation of central glucocorticoid receptor expression using antisense oligonucleotide technology
… in vitro and in vivo, with empirically-designed antisense oligodeoxynucleotides (ODN), to characterise GR modulation of 5-HT2A receptor expression using quantitative RT-PCR, Western blot analysis and radioligand binding. The functional consequence of GR downregulation is also determined by …
-
Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene
Duchene Muscular Dystrophy (DMD), and the milder allelic Becker muscular dystrophy (EMD), are X-linked recessive muscle wasting disorders characterised by mutations in the dystrophin gene. DMD occurs at a frequency of approximately 1 in 3500 male newborns and life expectancy is typically less than …
-
Liposome encapsulation enhances the anti-inflammatory activity of an ICAM-1 antisense oligonucleotide
Antisense oligonucleotides are designed to specifically bind to a variety of DNA and RNA targets to inhibit the translation of the genetic code into protein. By targeting disease-associated proteins this technology offers the potential for rapid design of highly specific drugs. However, the …
-
Molecular and preclinical aspects of antisense oligonucleotide treatment for myotonic dystrophy type 1
… Currently, there is no cure available for DM1. Antisense oligonucleotides (AONs) complementary to the (CUG)n repeat constitute a promising tool for treatment of DM1. We performed a broad screening of chemically modified (CAG)n AONs for their ability to reduce expanded DMPK mRNA levels. We found …
-
EXPLORING ANTISENSE OLIGONUCLEOTIDE THERAPY TARGETING PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE S IN C9ORF72-ALS/FTD
… cause of ALS and FTD. Translation of sense and antisense G4C2 repeat expansion produces neurotoxic dipeptide repeat (DPR) proteins. Among the various dipeptide repeat proteins, poly-GR and PR are relatively more toxic to neurons, positioning poly-GR and PR as a potential target to mitigate …
-
Prevention of influenza viral pneumonia using zanamivir and antisense oligonucleotide against inducible nitric oxide synthase /
… of this study - to evaluate if zanamivir and/or antisense oligonucleotide against inducible nitric oxide synthase prevents influenza viral pneumonia. During the experiment, the mice were infected with the influenza virus and treated with zanamivir, antisense oligonucleotide against iNOS or a …
-
Investigating the Effect of miR-145-5p Inhibition with an Antisense Oligonucleotide on Experimental Autoimmune Encephalomyelitis
… to determine if inhibition of miR-145-5p with an antisense oligonucleotide (ASO) is sufficient to protect mice from EAE. Female mice were induced with EAE and then treated with a control or miR-145 ASO at the onset of disease. We evaluated disease progression by monitoring clinical severity, and …
-
Identification of Antisense Oligonucleotide Internalization and Transport by Scavenging Receptor Proteins in Liver Sinusoidal Endothelial Cells
Antisense Oligonucleotides (ASOs) are an emerging field of gene therapeutics. These drugs are small DNA/RNA hybrid nucleoside polymers that modulate mRNA levels of targets identified in the progression of the specific disease. ASOs have multiple mechanisms and chemistries that may be utilized, with …
-
An intratumoral controlled release formulation of clusterin antisense oligonucleotide and paclitaxel or docetaxel for treatment of prostate tumors
… delivery of both phosphorothioated clusterin antisense oligonucleotide (clusterin ASO) and paclitaxel or docetaxel to prostate tumors to maintain therapeutic concentrations of the agents at the target disease site was investigated in this work. The primary objectives were to develop and …
-
An intratumoral controlled release formulation of clusterin antisense oligonucleotide and paclitaxel or docetaxel for treatment of prostate tumors
Surgical procedures performed on blood vessels may cause irritation of the vessel wall. This irritation sets off a series of complicated steps, which results in a growth of the vessel wall towards the center of the blood vessel, and a narrowing of the amount of space for the blood to flow through. …
-
Characterization of an antisense oligonucleotide targeted at Phospholipase C gamma 1 in the mouse T-cell line EL4.1L-2
… Therefore, in this study, we characterized an antisense oligonucleotide (ASO) against PLCgamma1 and study its effect on T cell activation. ASOs complementary to mouse PLCgamma1 mRNA were designed and screened in the mouse T cell line, EL4.IL-2. Among all, ASO3 showed the highest PLCgamma1 …
-
A study of a murine model of Aristolochic Acid Nephropathy and the impact of Antisense Oligonucleotide therapy targeting Kras
… then used to target Kras transcription with an Antisense Oligonucleotide (ASO) in the peri AKI period with the aim of reducing downstream fibrosis. <br/>CD1 mice were given two doses of 3.5mg/kg Aristolochic Acid via intraperitoneal injections, the first on Day 1 and the second on Day 5. The …
Page 1 of 8